These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 25210868)

  • 1. Advances in the management of asymptomatic myeloma.
    Mateos MV
    Curr Opin Oncol; 2014 Nov; 26(6):670-6. PubMed ID: 25210868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of asymptomatic myeloma patients.
    Mateos MV
    Expert Rev Hematol; 2015 Feb; 8(1):19-27. PubMed ID: 25363073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New approaches to smoldering myeloma.
    Mateos MV; San Miguel JF
    Curr Hematol Malig Rep; 2013 Dec; 8(4):270-6. PubMed ID: 23975678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Changing Landscape of Smoldering Multiple Myeloma: A European Perspective.
    Caers J; Fernández de Larrea C; Leleu X; Heusschen R; Zojer N; Decaux O; Kastritis E; Minnema M; Jurczyszyn A; Beguin Y; Wäsch R; Palumbo A; Dimopoulos M; Mateos MV; Ludwig H; Engelhardt M
    Oncologist; 2016 Mar; 21(3):333-42. PubMed ID: 26921288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significant changes in diagnostic and therapeutic procedures in smoldering multiple myeloma].
    Jurczyszyn A; Olszewska-Szopa M; Skotnicki AB
    Przegl Lek; 2015; 72(11):642-8. PubMed ID: 27012123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smoldering Multiple Myeloma: Who and When to Treat.
    Mateos MV; González-Calle V
    Clin Lymphoma Myeloma Leuk; 2017 Nov; 17(11):716-722. PubMed ID: 28709797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lenalidomide plus dexamethasone for high-risk smoldering multiple myeloma.
    Mateos MV; Hernández MT; Giraldo P; de la Rubia J; de Arriba F; López Corral L; Rosiñol L; Paiva B; Palomera L; Bargay J; Oriol A; Prosper F; López J; Olavarría E; Quintana N; García JL; Bladé J; Lahuerta JJ; San Miguel JF
    N Engl J Med; 2013 Aug; 369(5):438-47. PubMed ID: 23902483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoldering multiple myeloma.
    Gao M; Yang G; Kong Y; Wu X; Shi J
    Biomed Res Int; 2015; 2015():623254. PubMed ID: 26000300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The road to treating smoldering multiple myeloma.
    Korde N; Mailankody S; Landgren O
    Clin Lymphoma Myeloma Leuk; 2014 Sep; 14 Suppl():S59-64. PubMed ID: 25486957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MGUS and Smoldering Multiple Myeloma: Diagnosis and Epidemiology.
    Mateos MV; Landgren O
    Cancer Treat Res; 2016; 169():3-12. PubMed ID: 27696254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smoldering Multiple Myeloma: Emerging Concepts and Therapeutics.
    Sundararajan S; Kumar A; Korde N; Agarwal A
    Curr Hematol Malig Rep; 2016 Apr; 11(2):102-10. PubMed ID: 26894382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smoldering multiple myeloma: to treat or not to treat.
    Gentile M; Offidani M; Vigna E; Corvatta L; Recchia AG; Morabito L; Martino M; Morabito F; Gentili S
    Expert Opin Pharmacother; 2015 Apr; 16(6):785-90. PubMed ID: 25659943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2021 European Myeloma Network review and consensus statement on smoldering multiple myeloma: how to distinguish (and manage) Dr. Jekyll and Mr. Hyde.
    Musto P; Engelhardt M; Caers J; Bolli N; Kaiser M; Van de Donk N; Terpos E; Broijl A; De Larrea CF; Gay F; Goldschmidt H; Hajek R; Vangsted AJ; Zamagni E; Zweegman S; Cavo M; Dimopoulos M; Einsele H; Ludwig H; Barosi G; Boccadoro M; Mateos MV; Sonneveld P; Miguel JS
    Haematologica; 2021 Nov; 106(11):2799-2812. PubMed ID: 34261295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smoldering multiple myeloma: when to observe and when to treat?
    Mateos MV; San Miguel JF
    Am Soc Clin Oncol Educ Book; 2015; ():e484-92. PubMed ID: 25993213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding high-risk smoldering multiple myeloma.
    Kreiniz N; Gertz MA
    Leuk Lymphoma; 2023; 64(8):1361-1372. PubMed ID: 37229535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Smoldering multiple myeloma].
    Fouquet G; Guidez S; Herbaux C; Demarquette H; Leleu X
    Rev Med Interne; 2014 Apr; 35(4):243-9. PubMed ID: 24050785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smoldering Multiple Myeloma: To Treat or Not to Treat.
    Kapoor P; Rajkumar SV
    Cancer J; 2019; 25(1):65-71. PubMed ID: 30694862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoldering multiple myeloma: pathophysiologic insights, novel diagnostics, clinical risk models, and treatment strategies.
    Kazandjian D; Mailankody S; Korde N; Landgren O
    Clin Adv Hematol Oncol; 2014 Sep; 12(9):578-87. PubMed ID: 25654479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Advances in the Management of Smoldering Multiple Myeloma.
    Madhira BR; Konala VM; Adapa S; Naramala S; Ravella PM; Parikh K; Gentile TC
    World J Oncol; 2020 Apr; 11(2):45-54. PubMed ID: 32284772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smoldering multiple myeloma: natural history and recognition of an evolving type.
    Rosiñol L; Bladé J; Esteve J; Aymerich M; Rozman M; Montoto S; Giné E; Nadal E; Filella X; Queralt R; Carrió A; Montserrat E
    Br J Haematol; 2003 Nov; 123(4):631-6. PubMed ID: 14616966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.